BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 12541093)

  • 21. Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.
    Tsutamoto T; Tanaka T; Sakai H; Nishiyama K; Fujii M; Yamamoto T; Nakae I; Ohnishi M; Wada A; Horie M
    Circ J; 2008 May; 72(5):740-6. PubMed ID: 18441453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial sympathetic innervation and long-term left ventricular mechanical unloading.
    Drakos SG; Athanasoulis T; Malliaras KG; Terrovitis JV; Diakos N; Koudoumas D; Ntalianis AS; Theodoropoulos SP; Yacoub MH; Nanas JN
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):64-70. PubMed ID: 20129533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic and hormonal effects of the angiotensin II antagonist, candesartan cilexetil, in patients with congestive heart failure.
    Yoshimura M; Yasue H
    Cardiology; 2000; 93(3):175-82. PubMed ID: 10965089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
    McMurray JJ; Ostergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA;
    Lancet; 2003 Sep; 362(9386):767-71. PubMed ID: 13678869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
    McMurray JJ; Pitt B; Latini R; Maggioni AP; Solomon SD; Keefe DL; Ford J; Verma A; Lewsey J;
    Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of the angiotensin-converting enzyme inhibitor enalapril on chronic heart failure. Examination by 123I-MIBG imaging.
    Soeki T; Tamura Y; Bandou K; Tanaka H; Takeichi N; Shinohara H; Yui Y; Fukuda N; Sui O
    Jpn Heart J; 1998 Nov; 39(6):743-51. PubMed ID: 10089936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between cardiac 123I-metaiodobenzylguanidine imaging and the transcardiac gradient of neurohumoral factors in patients with dilated cardiomyopathy.
    Matsui T; Tsutamoto T; Kinoshita M
    Jpn Circ J; 2001 Dec; 65(12):1041-6. PubMed ID: 11767995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure.
    Groenning BA; Nilsson JC; Hildebrandt PR; Kjaer A; Fritz-Hansen T; Larsson HB; Sondergaard L
    Eur J Heart Fail; 2002 Oct; 4(5):635-46. PubMed ID: 12413508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
    van Kraaij DJ; Jansen RW; Sweep FC; Hoefnagels WH
    Eur J Heart Fail; 2003 Jan; 5(1):47-53. PubMed ID: 12559215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization induces favorable neurohumoral changes.
    Erol-Yilmaz A; Verberne HJ; Schrama TA; Hrudova J; De Winter RJ; Van Eck-Smit BL; De Bruin R; Bax JJ; Schalij MJ; Wilde AA; Tukkie R
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):304-10. PubMed ID: 15826264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
    Sakata K; Yoshida H; Obayashi K; Ishikawa J; Tamekiyo H; Nawada R; Doi O
    J Hypertens; 2002 Jan; 20(1):103-10. PubMed ID: 11791032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure.
    Sheth T; Parker T; Block A; Hall C; Adam A; Pfeffer MA; Stewart DJ; Qian C; Rouleau JL;
    Am J Cardiol; 2002 Sep; 90(5):496-500. PubMed ID: 12208409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
    Boccanelli A; Cacciatore G; Mureddu GF; de Simone G; Clemenza F; De Maria R; Di Lenarda A; Gavazzi A; Latini R; Masson S; Porcu M; Vanasia M; Gonzini L; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):683-91. PubMed ID: 17700397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.